AbbVie
ABBV
$185.30
Share price
-0.10%
Change (1 day)
8.75%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Number of shares outstanding for AbbVie (ABBV)
Number of shares outstanding as of June 2025 : 1,768,000,000
According to AbbVie's latest financial reports and stock price the company's current number of shares outstanding is 1,768,000,000. At the end of 2025 the company had 1,768,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AbbVie from 2011 to 2025
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 1.76 B | 0.16% |
| 2024 | 1.76 B | -0.04% |
| 2023 | 1.76 B | -0.18% |
| 2022 | 1.76 B | 0.05% |
| 2021 | 1.76 B | 0.18% |
| 2020 | 1.76 B | 19.35% |
| 2019 | 1.47 B | 0.01% |
| 2018 | 1.47 B | -7.12% |
| 2017 | 1.59 B | -0.02% |
| 2016 | 1.59 B | -1.08% |
| 2015 | 1.60 B | 1.16% |
| 2014 | 1.59 B | 0.25% |
| 2013 | 1.58 B | 0.47% |
| 2012 | 1.58 B | -2.23% |
| 2011 | 1.61 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,675,000,000 | 220.98% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,031,000,000 | 14.88% | 🇺🇸 USA |
 Eli Lilly LLY | 897,989,151 | -49.21% | 🇺🇸 USA |
 Amgen AMGN | 538,000,000 | -69.57% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,246,000,000 | -29.52% | 🇺🇸 USA |
 Biogen BIIB | 146,100,000 | -91.74% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,038,500,000 | 15.30% | 🇬🇧 UK |
 AstraZeneca AZN | 3,100,000,000 | 75.34% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | 99,700,000 | -94.36% | 🇺🇸 USA |